Differential effects of heparin and low molecular weight heparin on osteoblastogenesis and adipogenesis in vitro

Thrombosis and Haemostasis

Volumn 92, Issue 4, 2004, Pages 803-810

  Osip, Stephanie L ^a   Butcher, Martin ^a   Young, Edward ^a   Yang, Lufang ^a   Shaughnessy, Stephen G ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Adipogenesis; Bone; Heparin; Low molecular weight heparin; Osteoblastogenesis

Indexed keywords

ALKALINE PHOSPHATASE; DALTEPARIN; HEPARIN; HEPARIN DERIVATIVE; LOW MOLECULAR WEIGHT HEPARIN;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STROMA CELL;

ADIPOCYTES; ANIMALS; BIOLOGICAL MARKERS; CELL COUNT; CELL DIFFERENTIATION; FEMUR; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; MICE; OSTEOBLASTS; STROMAL CELLS;

EID: 6344291877     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-03-0199     Document Type: Article

References (36)

1. Dahlman TC. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol 1993; 168: 1265-70.
2. Monreal M, Lafoz E, Olive A, et al. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin. Thromb Heamost 1994; 71: 7-11.
3. Douketis JD, Ginsberg JS, Burrows RF, et al. The effects of long-term heparin therapy during pregnancy on bone density. Thromb Haemost 1996; 75: 254-7.
4. Pettila V, Leinonen P, Markkola A, et al. Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin. Thromb Haemost 2002; 87: 182-6.
5. Wawrzynska L, Tomkowski WZ, Przedlacki J, et al. Changes in bone density during long-term administration of low-molecular-weight heparins or acenocoumarol for secondary prophylaxis of venous thromboembolism. Pathophysiol Haemost Thromb 2003; 33: 64-7.
6. Muir JM, Weitz JI, Andrew M, et al. A histomorphometric comparison of the effects of heparin and low molecular weight heparin on cancellous bone in rats. Blood 1997; 89: 3236-42.
7. Kajkenova O, Lecka-Czernik B, Gubrij I, et al. Increased adipogenesis and myelopoeisis in the bone marrow of samp6, a murine model of defective osteoblastogenesis and low turnover osteopenia. J Bone Miner Res 1997; 12: 1772-9.
8. Hicok K, Thomas T, Gori F, et al. Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma. J Bone Miner Res 1998;13: 205-17.
9. Thompson D, Lum K, Nygaard S, et al. The derivation and characterization of stromal cell lines from the bone marrow of p53-/- mice: new insights into osteoblast and adipocyte differentiation. J Bone Miner Res 1998; 13: 195-204.
10. Nuttal ME, Patton A, Olivera D, et al. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype:implications for osteopenic disorders. J Bone Miner Res 1998;13: 371-82.
11. Lecka-Czernik B, Moerman EJ, Grant DF, et al. Divergent effects of selective peroxisome proliferator-activated receptor-γ2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 2002; 143: 2376-84.
12. Diascro DD, Vogel R, Johnson T, et al. High fatty acid content in rabbit serum is responsible for the differentiation of osteoblasts into adipocyte-like cells. J Bone Miner Res 1998;13: 96-106.
13. Poliard A, Nifuji A, Lamblin D, et al. Controlled conversion of an immortalized mesodermal progenitor cell towards osteogenic, chondrogenic, or adipogenic pathways. J Cell Biol 1995; 130: 1461-72.
14. Beresford J, Bennett J, Devlin C, et al. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 1992; 102: 341-51.
15. Tholpady SS, Katz AJ, Ogle RC. Mesenchymal stem cells from rat visceral fat exhibit multipotential differentiation in vitro. Anat Rec 2003; 272A: 398-402.
16. Noth U, Osyczka AM, Tuli R, et al. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 2002; 20: 1060-9.
17. Ducy P, Zhang R, Geoffroy V, et al. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997; 89: 747-54.
18. Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002; 108: 17-29.
19. Shui C, Spelsberg TC, Riggs BL, et al. Changes in Runx2/Cbfal expression and activity during osteoblastic differentiation of human bone marrow stromal cells. J Bone Miner Res 2003; 18: 213-21.
20. Zheng H, Guo Z, Ma Q, et al. Cbfa1/osf2 transduced bone marrow stromal cells facilitate bone formation in vitro and in vivo. Calcif Tissue Int 2004; 74: 194-203.
21. Bellows CG, Wang YH, Heersche JNM, et al. 1,25-dihydroxyvitamin D stimulates adipocyte differentiation in cultures of fetal rat calvaria cells: comparison with the effects of dexamethasone. Endocrinology 1994; 134: 2221-9.
22. Shaughnessy SG, Young E, Deschamps, et al. The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria. Blood 1995; 86: 1368-73.
23. Bhandari M, Hirsh J, Weitz JI, et al. The effects of standard and low molecular weight heparin on bone nodule formation in vitro. Thromb Haemost 1998; 80: 413-7.
24. Mishina Y, Starbuck MW, Gentile MA, et al. BMP type IA receptor signaling regulates postnatal osteoblast function and bone remodeling. J Biol Chem 2004; 10: 1074.
25. Skillington J, Choy L, Derynck R. Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes. J Cell Biol 2002; 159: 135-46.
26. Gimble JM, Morgan C, Kelly K, et al. Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells. J Cell Biochem 1995; 58: 393-402.
27. Doerrier W, Feingold KR, Grunfeld C. Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms. Cytokine 1994; 6: 478-84.
28. Hurley MM, Kessler M, Gronowicz G, et al. The interaction of heparin and basic fibroblast growth factor on collagen synthesis in 21 day fetal rat calvariae. Endrocrinology 1992; 130: 2675-82.
29. Aubin JE. Regulation of osteoblast formation and function. Rev Endocr Metab Disord 2001; 2: 81-94.
30. Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev 1998; 78: 783-809.
31. Knock HJ, Handschin AE. Inhibition of human osteoblast growth by unfractionated heparin and by low molecular weight heparins in vitro. Thromb Haemost 2002; 88: 361-2.
32. Cosmi B, Fredenburgh JC, Rischke J, et al. Effect of nonspecific binding to plasma proteins on the antithrombin activities of unfractionated heparin, low-molecular-weight heparin, and dermatan sulfate. Circulation 1997; 95: 118-24.
33. Young E, Wells P, Holloway S, et al. Ex-vivo and in-vitro evidence that low molecular weight heparins exhibit less binding to plasma proteins than unfractionated heparin. Thromb Haemost 1994; 71: 300-4.
34. Barzu T, Molho P, Tobelem G, et al. Heparin degradation in the endothelial cells. Thromb Res 1987; 47: 601-9.
35. Hurley MM, Kream BE, Raisz LG. Structural determinants of the capacity of heparin to inhibit collagen synthesis in 21-day fetal rat calvariae. J Bone Min Res 1990; 5: 1127-32.
36. Levine MN, Hirsh J, Gent M, et al. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. Arch Intern Med 1994; 154: 49-56.